SSTR2 and neoplasm: In all sampled tumours, SST2 expression, which was primarily localised to the cell membrane, was very strong (H-score of 300) independently of the administered treatments (vehicle, [177Lu]Lu-satoreotide tetraxetan, or [177Lu]Lu-DOTA-TATE at any dose) (Figure 3).